Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05610189 · ClinicalTrials.gov registry record · Phase 1

Multiple-dose Trial to Determine the Clinical Bioequivalence Between Tavapadon Tablets in Participants With Parkinson's Disease

A Phase 1 study of Parkinson Disease, sponsored by Cerevel Therapeutics.

Completed
Registry status
Phase 1
Development phase
25
Enrollment target
6
Study locations

NCT05610189 is a Phase 1 study of Parkinson Disease that has completed, run by Cerevel Therapeutics. The registered enrollment target is 25 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 6 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05610189, a Phase 1 study of Parkinson Disease, has completed, sponsored by Cerevel Therapeutics.

COMPLETED
Registry status
Phase 1
Development phase
25 participants
Enrollment target
6
Study locations

Study Summary

The primary purpose of the study is to evaluate the bioequivalence (BE) of tavapadon 15 milligram (mg) tablet to 3x5 mg tablets in participants with Parkinson's disease.

Conditions Studied

Parkinson Disease

Interventions

  • DRUG Tavapadon

Study Locations (6)

Florida

  • Hollywood, Florida - Hollywood
  • Orlando, Florida - Orlando
  • South Miami, Florida - South Miami

California

  • Los Alamitos, California - Los Alamitos

Georgia

  • Decatur, Georgia - Decatur

Michigan

  • Farmington Hills, Michigan - Farmington Hills

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2022-12-15
Est. Completion 2023-12-17
Phase Phase 1

Sponsor

Cerevel Therapeutics

21 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05610189

The ClinicalTrials.gov registry entry for NCT05610189 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is Cerevel Therapeutics, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Tavapadon is the first listed.

NCT05610189 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Florida, California, Georgia.

Frequently Asked Questions

What is clinical trial NCT05610189 about?

NCT05610189 is a clinical study titled "Multiple-dose Trial to Determine the Clinical Bioequivalence Between Tavapadon Tablets in Participants With Parkinson's Disease". The primary purpose of the study is to evaluate the bioequivalence (BE) of tavapadon 15 milligram (mg) tablet to 3x5 mg tablets in participants with Parkinson's disease.

What is the current status of trial NCT05610189?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2022-12-15. Estimated completion is 2023-12-17.

What conditions does trial NCT05610189 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT05610189?

The interventions under investigation include: Tavapadon (DRUG).

Who is sponsoring clinical trial NCT05610189?

This trial is sponsored by Cerevel Therapeutics, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05610189 being conducted?

This trial has 6 study locations across California, Florida, Georgia, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.